Publications

Recent publications 

Find here all our publications

Sion, A., Martin, M., Bonhomme, M., Josse, J., Valour, F., Laurent, F., Dupieux, C., 2026. In vitro antibiofilm and intracellular activity of delafloxacin against Staphylococcus aureus and Staphylococcus epidermidis in bone and joint infections. Microbiol Spectr e0246125. https://doi.org/10.1128/spectrum.02461-25

Berrada, M., Kolenda, C., Tristan, A., Laurent, F., Dupieux, C., 2026. Could oritavancin be a promising alternative treatment for staphylococcal bone and joint infections? Insights from the determination of oritavancin minimum inhibitory concentrations in a collection of clinical isolates from the French National reference centre for staphylococci. Eur J Clin Microbiol Infect Dis. https://doi.org/10.1007/s10096-025-05383-3

Crepin, D.M., Bonhomme, M., Faure, A., Sinel, C., Bergot, M., Dyon-Tafani, V., Maali, Y., Bouvard, D., Diot, A., Laurent, F., Josse, J., 2025. Staphylococcal internalization into osteoblasts: a partially conserved mechanism across the genus. mBio e0169725. https://doi.org/10.1128/mbio.01697-25

Médalin, A., Youenou, B., Badiou, C., Desbiolles, C., Prat, R., Vandenesch, F., Lemoine, J., Girod, M., 2025. Quantification of Staphylococcal Enterotoxins by Coupling Laser-Induced Dissociation and Mass Spectrometry. J Am Soc Mass Spectrom. https://doi.org/10.1021/jasms.5c00261

Burdet, C., Saïdani, N., Dupieux, C., Lemaignen, A., Canouï, E., Surgers, L., Vareil, M.O., Lefort, A., Lepeule, R., Peiffer-Smadja, N., Charmillon, A., Le Moing, V., Boutoille, D., Tolsma, V., Abgrall, S., Wolff, M., Tattevin, P., Esposito-Farèse, M., Vandenesch, F., Duval, X., Tubiana, S., Lescure, F.-X., CloCeBa Study Group, 2025. Cloxacillin versus cefazolin for meticillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): a prospective, open-label, multicentre, non-inferiority, randomised clinical trial. Lancet S0140-6736(25)01624–1. https://doi.org/10.1016/S0140-6736(25)01624-1

Teixeira, C., Vandenesch, F., Moreau, K., 2025. tRNA modifications as regulators of bacterial virulence and stress responses. PLoS Pathog 21, e1013600. https://doi.org/10.1371/journal.ppat.1013600

Hilmarsdóttir, I., Helgason, K.O., Thórsdóttir, Á., Bonhomme, M., Stefánsdóttir, J.D., Jelle, Á.E., Thórkelsson, T., Laurent, F., Butin, M., 2025. Neonatal infection with Staphylococcus capitis NRCS-A in Iceland: A 12-year longitudinal, retrospective study of strains from patients, staff and the environment in a neonatal intensive care unit. Antimicrob Resist Infect Control 14, 107. https://doi.org/10.1186/s13756-025-01623-5

Marro, F.C., Brocard, J., Faure, A., Sion, A., Verhoeven, P.O., Canonne-Desbiolles, L., Conraux, L., Jaffrelot, L., Monlong, C., Blocker, A.J., Dubarry, N., Laurent, F., Josse, J., 2025. Monitoring intracellular replication dynamics unveils high proportion of non-replicating antibiotic-tolerant Staphylococcus aureus inside osteoblasts. PLoS Pathog 21, e1013525. https://doi.org/10.1371/journal.ppat.1013525

Collet, Q., Velard, F., Laurent, F., Josse, J., 2025. Intracellular Staphylococcus aureus in osteoblasts and osteocytes and its impact on bone homeostasis during osteomyelitis. Bone 198, 117536. https://doi.org/10.1016/j.bone.2025.117536

El Boussarghini, K., Butin, M., Loppinet, T., Portefaix, A., Gillet, Y., Tristan, A., Panetta, L., 2025. Neonatal Staphylococcus aureus Bacteremia: A 12-year Retrospective Study on Treatment Duration and Relapse. Pediatr Infect Dis J. https://doi.org/10.1097/INF.0000000000004909

Costes, F., Nilly, F., Rousset, A., Pont, S., Moreau, K., Blanc-Potard, A.-B., 2025. Modeling Pseudomonas aeruginosa-Staphylococcus aureus interactions in zebrafish to assess the host inflammatory response upon co-infection. Sci Rep 15, 23965. https://doi.org/10.1038/s41598-025-08459-4

Edslev, Sofie M., Laurent, F., Månsson, E., Johannesen, T.B., Aarris, M., Sönksen, U.W., Kolenda, C., Söderquist, B., Stegger, M., 2025. Antibiotic resistance and population structure of Staphylococcus epidermidis from prosthetic joint infections in Sweden and France. J Antimicrob Chemother 80, 2007–2015. https://doi.org/10.1093/jac/dkaf166

André, C., Medina, M., Kolenda, C., Blazière, L., Helluin, E., Resch, G., Bispo, P.J.M., Laurent, F., 2025. In Vitro Activity of Bacteriophages Against Ocular Methicillin-resistant S. aureus Isolates Collected in the US. Ophthalmol Ther 14, 897–909. https://doi.org/10.1007/s40123-025-01113-2

Edslev, Sofie Marie, Aarris, M., Nielsen, K.L., Hertz, F.B., Johannesen, T.B., Kolenda, C., Laurent, F., Månsson, E., Söderquist, B., Stegger, M., 2025. rpoB mutations and their association with rifampicin resistance in clinical Staphylococcus epidermidis. J Antimicrob Chemother 80, 1067–1071. https://doi.org/10.1093/jac/dkaf035

Martins Simões, P., van der Mee-Marquet, N., Youenou, B., Ranc, A.-G., Dupieux-Chabert, C., Menard, G., Dupin, C., Butin, M., Vandenesch, F., Laurent, F., Berger-Carbonne, A., Kolenda, C., Tristan, A., S. haemolyticus neonatal infections Study Group, 2025. Epidemiology of Staphylococcus haemolyticus nosocomial bacteraemia in neonatal intensive care units, France, 2019 to 2023: predominance of the ST29 (CC3) multidrug-resistant lineage. Euro Surveill 30, 2400309. https://doi.org/10.2807/1560-7917.ES.2025.30.11.2400309

Ranc, A.-G., Simões, P.M., Youenou, B., Kolenda, C., Dupieux, C., Laurent, F., Rasigade, J.P., Tristan, A., Vandenesch, F., 2025. Gradual loss of mobile genetic elements in Staphylococcus aureus USA300 in a closed hospital niche. ISME Commun 5, ycaf105. https://doi.org/10.1093/ismeco/ycaf105

Maucotel, A.L., Crepin, D.M., Faure, A., Valour, F., Laurent, F., Josse, J., 2025. Pathogenesis of Staphylococcus epidermidis prosthetic joint infections: bacterial adhesion and internalization in osteoblasts, synoviocytes and endothelial cells. J Med Microbiol 74. https://doi.org/10.1099/jmm.0.001959